These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33375513)

  • 1. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
    Shabbir U; Rubab M; Tyagi A; Oh DH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.
    Bukhari SN; Jantan I
    Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcuminoids and resveratrol as anti-Alzheimer agents.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):515-25. PubMed ID: 23276553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
    Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
    Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
    Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Tonk S; Kuruva CS; Bhatti JS; Kandimalla R; Vijayan M; Kumar S; Wang R; Pradeepkiran JA; Ogunmokun G; Thamarai K; Quesada K; Boles A; Reddy AP
    J Alzheimers Dis; 2018; 61(3):843-866. PubMed ID: 29332042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of curcumin nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment.
    Lv H; Wang Y; Yang X; Ling G; Zhang P
    Nutr Neurosci; 2023 Aug; 26(8):727-742. PubMed ID: 35694842
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.
    Pluta R; Furmaga-Jabłońska W; Januszewski S; Czuczwar SJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.
    Li L; Wang F; Jia X; Yao L; Liu Y
    Mini Rev Med Chem; 2024; 24(17):1590-1601. PubMed ID: 37929738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):554-64. PubMed ID: 23276558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer's disease.
    Assi AA; Farrag MMY; Badary DM; Allam EAH; Nicola MA
    Inflammopharmacology; 2023 Jun; 31(3):1449-1464. PubMed ID: 36856916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.
    Chainoglou E; Hadjipavlou-Litina D
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
    Serafini MM; Catanzaro M; Rosini M; Racchi M; Lanni C
    Pharmacol Res; 2017 Oct; 124():146-155. PubMed ID: 28811228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
    Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
    J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer's Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model.
    Su IJ; Chang HY; Wang HC; Tsai KJ
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy.
    Wan Y; Liang Y; Liang F; Shen N; Shinozuka K; Yu JT; Ran C; Quan Q; Tanzi RE; Zhang C
    J Alzheimers Dis; 2019; 72(3):761-771. PubMed ID: 31640096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review.
    Pei J; Palanisamy CP; Natarajan PM; Umapathy VR; Roy JR; Srinivasan GP; Panagal M; Jayaraman S
    Ageing Res Rev; 2024 Aug; 99():102393. PubMed ID: 38925479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease.
    Mazahir F; Yadav AK
    CNS Neurol Disord Drug Targets; 2023; 22(4):477-499. PubMed ID: 35450536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.